Adverse cardiac events in patients with coronary stents undergoing noncardiac surgery: a systematic review.

BACKGROUND When patients with drug-eluting stents (DES) present for surgery, current guidelines recommend delaying elective surgeries until 1 year of dual antiplatelet therapy has been completed. METHODS We performed a systematic literature review of the major adverse cardiac events (MACE) associated with noncardiac surgery in patients with DES. RESULTS… CONTINUE READING